CCK-58



CCK-58

V1VV1S2SS2Q3QQ3R4RR4T5TT5D6DD6G7GG7E8EE8S9SS9R10RR10A11AA11H12HH12L13LL13G14GG14A15AA15L16LL16L17LL17A18AA18R19RR19Y20YY20I21II21Q22QQ22Q23QQ23A24AA24R25RR25K26KK26A27AA27P28PP28S29SS29G30GG30R31RR31M32MM32S33SS33I34II34V35VV35K36KK36N37NN37L38LL38Q39QQ39N40NN40L41LL41D42DD42P43PP43S44SS44H45HH45R46RR46I47II47... and 11 more residue(s)...... and 11 more residue(s)

SMILES None
InChIKey None
Sequence VSQRTDGESRAHLGALLARYIQQARKAPSGRMSIVKNLQNLDPSHRISDRDYMGWMDF

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCK-58

V1VV1S2SS2Q3QQ3R4RR4T5TT5D6DD6G7GG7E8EE8S9SS9R10RR10A11AA11H12HH12L13LL13G14GG14A15AA15L16LL16L17LL17A18AA18R19RR19Y20YY20I21II21Q22QQ22Q23QQ23A24AA24R25RR25K26KK26A27AA27P28PP28S29SS29G30GG30R31RR31M32MM32S33SS33I34II34V35VV35K36KK36N37NN37L38LL38Q39QQ39N40NN40L41LL41D42DD42P43PP43S44SS44H45HH45R46RR46I47II47... and 11 more residue(s)...... and 11 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.